Brand name: Elmiron TM
Active ingredients: pentosan polysulfate sodium
What it is used for
INDICATIONS AS AT 5 August 2021: ELMIRON is indicated for the treatment of interstitial cystitis. Relief of symptoms in patients with interstitial cystitis may not be experienced until 6 to 8 weeks of therapy with ELMIRON. Continuing long-term therapy is necessary for persistent relief of symptoms. Relief of symptoms may not occur in all patients, and relapse is likely to occur gradually if treatment is discontinued, even after long periods of therapy.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White hard gelatin capsules imprinted 'ELM' with black printing ink.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient pentosan polysulfate sodium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
